drugset

drugset / Trial / NCT05669872

Patient Blood Mangement (PBM) Using IV Iron in Patients With Gynecologic Cancer

NCT05669872 ↗

Unknown 334 enrolled Asan Medical Center

RandomizedParallel-groupOpen-labelSupportive care

Summary

To demonstrate the safety and effectiveness of a patient blood management program in gynecological cancer patients

Timeline

Start: 2023-02
Primary completion: 2025-06
Completion: 2025-12

Publications

Park JY, Kang OJ, Lee YY, Kim YS. A prospective randomized controlled trial evaluating the safety and efficacy of patient blood management program in patients with gynecologic cancer (KGOG 4011/PBM). Int J Gynecol Cancer. 2023 Jul 3;33(7):1140-1144. doi: 10.1136/ijgc-2023-004403.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ferric carboxymaltose	Other / unclassified	1000 mg	Intravenous

Indications